The recoverable amount of the EMEA CGU has been determined based on a value in use calculation using cash flow projections based on financial budgets covering a 5-year period approved by senior management.
Financial Information · p. 402
Assumptions were used in the value in use calculation of the EMEA CGU at the end of each of the Track Record Period.
Financial Information · p. 402
The values assigned to the key assumptions on compound growth rate of revenue, discount rate and terminal growth rate are consistent with external information sources.
Our goodwill arises from the acquisition of Actiontec Electronics.
Financial Information · p. 349
Our goodwill remained at RMB99.0 million as of December 31, 2022, 2023, and 2024, and June 30, 2025.
Financial Information · p. 349
As of December 31, 2022, 2023 and 2024, and June 30, 2025, based on the value-in-use calculations, the recoverable amount exceeded the carrying amount by RMB5,691,000, RMB30,468,000, RMB449,311,000, and RMB456,989,000, respectively.
As of December 31, 2022, 2023, and 2024, and June 30, 2025, the carrying amounts of these deferred development costs not yet available for use were RMB256.6 million, RMB286.5 million, and RMB133.1 million, and RMB143.1 million, respectively.
Financial Information · p. 348
The recoverable amounts of each intangible asset not yet available for use based on the estimated value-in-use calculations was higher than the respective carrying amount as of December 31, 2022, 2023 and 2024, and June 30, 2025.
Financial Information · p. 348
We have performed a sensitivity test by decreasing 5% of expected revenue or increasing 1% of discount rate, with all other key assumptions held constant, the recoverable amount of the intangible assets not yet available for use would have exceeded their carrying amount.
Our goodwill decreased by 95.9% from RMB311.2 million as of December 31, 2023 to RMB12.9 million as of December 31, 2024, primarily due to the Disposal of Rolling.
Financial Information · p. 317
Goodwill arising from our business is tested at least annually for impairment.
Financial Information · p. 318
Our intangible assets decreased by 32.5% from RMB367.5 million as of December 31, 2023 to RMB248.0 million as of December 31, 2024, primarily due to (i) a decrease in patent assets and (ii) a decrease in customer relationships assets, as a result of the Disposal of Rolling.
The goodwill of RMB9.9 million represents the excess of the acquisition consideration transferred and amount of controlling interests in Zhuhai Furun Technology Co., Ltd. (“Zhuhai Furun”), a provider of e-commerce ERP solutions over the fair value of the net identifiable assets acquired as at the acquisition date in July 2021 and was allocated on Zhuhai Furun.
Financial Information · p. 311
We have engaged an independent external appraiser to assist management to perform the goodwill impairment assessments.
Financial Information · p. 312
As of December 31, 2022, the recoverable amount of Zhuhai Furun is estimated to be lower than the carrying amount of the CGU.
Our intangible assets increased by 14.4% from RMB533.8 million as of December 31, 2023 to RMB610.6 million as of December 31, 2024 and further increased by 3.1% to RMB629.6 million as of June 30, 2025, primarily driven by an increase of research and development costs over the periods as we continued to invest in R&D activities to optimize our diversified and balanced pipeline of drug assets.
Financial Information · p. 459
Therefore, recoverable amounts exceed the carrying amounts with headroom of RMB789.9 million, RMB480.6 million and RMB606.6 million, respectively.
Financial Information · p. 460
The 1% decrease in the revenue growth rate or 1% increase in the pre-tax discount rate would not cause the carrying amount of each project to exceed its recoverable amount at the end of each period of the Track Record Period.
Impairment review on the deferred development costs of the Group is conducted by the management of the Group by engaging an independent qualified professional valuer, Jiangsu Zhongqihua Zhongtian Asset Appraisal Co., Ltd. (“Appraisal Expert”), to estimate the recoverable amount of the CGUs at the end of each year.
Financial Information · p. 410
For the years ended 31 December 2022, 2023 and 2024 and 31 March 2025, the management considered no reasonably possible change in the key assumptions mentioned above would cause the carrying amounts of the CGUs to exceed their recoverable amounts.
Financial Information · p. 414
The management determined that there was no impairment of its CGUs as of 31 December 2022, 2023 and 2024 and 31 March 2025.
The carrying value of our goodwill remained stable at RMB63.1 million as of December 31, 2022, 2023 and 2024, respectively.
Financial Information · p. 347
During the Track Record Period, we did not record any impairment loss on our goodwill.
Financial Information · p. 347
Considering there was still sufficient headroom based on the assessment, our management believes that a reasonably possible change in the above key parameters would not cause the carrying amount of the CGU to exceed its recoverable amount and would not result in an impairment provision of goodwill.
We recorded goodwill of RMB95.4 million, RMB95.4 million and RMB95.4 million as of December 31, 2022, 2023 and 2024, respectively, in relation to our acquisition of Chinese Peptide in June 2020, and the goodwill has been allocated to cash generating unit of Chinese Peptide and its subsidiaries for impairment testing.
Financial Information · p. 356
We engaged an independent third-party valuer to conduct annual goodwill impairment testing and did not record any impairment during the Track Record Period based on such testing.
Financial Information · p. 356
We believe that a reasonably possible change in the key parameters would not cause the carrying amount of the Chinese Peptide to exceed its recoverable amount as of December 31, 2022, 2023 and 2024.
As of December 31, 2024, our goodwill arose from our acquisition of subsidiaries operating postpartum centers in China, our GuangHeTang business, and our S-bra business which is held by Beikang Hanlian.
Financial Information · p. 397
In the opinion of our Group's management, during the Track Record Period, there was no impairment for the goodwill since the cash generating units' recoverable value exceed the carrying amount of the goodwill.
Financial Information · p. 397
We determine whether goodwill is impaired at least on an annual basis.
Our goodwill remained unchanged at RMB643.0 million as of December 31, 2022, 2023 and 2024.
Financial Information · p. 571
The recoverable amounts of the cash-generating units have been determined based on the higher of fair value less costs of disposal and value in use calculations of the underlying assets with reference to valuation reports issued by an independent valuer.
Financial Information · p. 505
As a result of the impairment tests, we are of the view that there was no impairment of goodwill as of December 31, 2022, 2023 and 2024. Reasonably possible changes in key assumptions would not lead to impairment as of December 31, 2022, 2023 and 2024.
The decrease in goodwill from RMB210.4 million as of December 31, 2023 to RMB112.9 million as of December 31, 2024 was primarily due to impairment losses of goodwill.
Financial Information · p. 298
Accordingly, goodwill allocated to the Honghe Hongbin CGU of RMB97.5 million was fully impaired and the relevant impairment loss was recognized in "provision for impairment losses" for the year ended December 31, 2024.
Financial Information · p. 299
Our Directors are of the view that, except for the Honghe Hongbin CGU, a reasonably possible change in a key parameter will not cause the carrying amount of the relevant CGUs to exceed the respective recoverable amounts as of December 31, 2022, 2023 and 2024, respectively.
Our management engaged an independent external valuer to assess the recoverable amounts of the goodwill as of December 31, 2022, 2023 and 2024.
Financial Information · p. 340
As of December 31, 2022, 2023 and 2024, based on the value-in-use calculations, the recoverable amount exceeded the carrying amount of SENADA BIKES CGU by RMB1,390,000, RMB12,010,000 and RMB8,747,000, respectively.
Financial Information · p. 340
Due to the proximity of the acquisition date of SENADA BIKES CGU to December 31, 2022, the appraised value of SENADA BIKES CGU as of December 31, 2022 is close to the consideration for acquisition of SENADA BIKES CGU, with a small headroom.
Our capitalized development costs included in intangible assets that were not yet available for use and not subject to amortization were RMB1,681.0 million, RMB2,492.5 million, and RMB3,837.6 million as of December 31, 2022, 2023 and 2024, respectively.
Financial Information · p. 384
Based on the result of annual impairment test, the recoverable amount of capitalized development costs would have exceeded their carrying amount (headroom) by more than 200% as of December 31, 2022, 2023 and 2024.
Financial Information · p. 384
Should the discount rate increase by 1% or expected revenue decrease by 10%, the headroom would have decreased by no more than 20% as of December 31, 2022, 2023 and 2024.
In 2024, we had impairment of goodwill of US$2.9 million because (i) an impairment of goodwill of US$0.8 million of Jianian as a result of the revenue generated from Jianian for the year was lower than the previous projection due to various factors, including but not limited to, intense market competition and changes in key marketing personnel, and (ii) an impairment of goodwill of US$2.1 million of Prime Heart because of our decision not to renew Prime Heart’s existing premise lease and cease the operations of Prime Heart by the end of June 2025 due to the absence of alternative space at a reasonable pricing and staff resources to continue delivering the full range of services.
Financial Information · p. 519
As a result, our management determined the recoverable amount of the Jianian’s CGU based on value-in-use calculations to be US$383,729, which is lower than its carrying amount and an impairment loss on goodwill of US$819,759 was recognized.
Financial Information · p. 546
Considering there was still sufficient headroom based on the assessment, our management believed that a reasonably possible change in any of the key assumptions on which our management have based the determination of the recoverable amount of each CGU would not cause its carrying amount to exceed its recoverable amount.
In 2022, 2023 and 2024, our impairment losses amounted to RMB4.0 billion, RMB6.1 billion and RMB9.3 billion, respectively.
Financial Information · p. 261
Our impairment losses increased from RMB4.0 billion in 2022 to RMB6.1 billion in 2023, primarily due to an increase in impairment losses related to our property, plant and equipment and intangible assets, primarily in relation to the upgrades or adjustments made to certain machinery, partially offset by a decrease in impairment losses on inventories.
Financial Information · p. 268
Our intangible assets decreased to RMB5.3 billion as of December 31, 2024, primarily related to the impairment of certain mining rights.
In view of the unfavorable future prospects of certain restaurants, we recognized an impairment loss of RMB4.6 million for the year ended December 31, 2023.
Financial Information · p. 300
Although certain restaurants recorded operating losses for the years ended December 31, 2022 and 2024, the recoverable amount of these restaurants with an indication of impairment exceeds the carrying amount.
As a result of the unexpected accelerated shift in market demand from P-type PERC cells to N-type TOPCon cells during the fourth quarter of 2023, we recognized a one-off impairment loss on property, plant and equipment of RMB894.2 million in 2023 on certain P-type PERC cell production lines and production facilities in our Shangrao Plant.
Financial Information · p. 388
We uses direct comparison approach to estimate the fair value less costs of disposal which is based on the recent transaction and market quoted prices for similar property, plant and equipment adjusted for nature, location and conditions.
Financial Information · p. 389
No further impairment was recognized in 2024 due to our determination on the recoverable amounts of these property, plant and equipment based on their fair value less costs of disposal using a market approach.